Manufacturer
ORION CORP
Contents
Dopamine HCl
Indication
Acute heart failure
Instruction
Dilute solution (usually 1.6 mg/mL or 3.2 mg/mL) in NaCl 0.9%, glucose 5%, or other suitable diluents.
Drug interaction
Cardiac effects are antagonised by β-adrenergic agents (e.g. propanolol, metoprolol). α-adrenergic blocking agents may antagonise the vasoconstricting effect of high dose dopamine. Prolonged and enhanced effect with MAOIs. Risk of hypotension and bradycardia with phenytoin. May enhance effect of diuretics. Risk of excessive vasoconstriction with ergot alkaloids. May enhance vasopressor effect with TCAs and guanethidine.Potentially Fatal: May enhance the arrhythmogenic effect with cyclopropane and halogenated hydrocarbon anaesthetics.
Malaysia
